February 5, 2026
Initial data demonstrates a 67% average drop in work time across cellular therapy procedures using Title21’s Standard of Care digital orchestration platform.
January 6, 2026
Title21 announces the acquisition of MyCellHub to accelerate Title21’s mission to deliver comprehensive, compliant, and integrated digital solutions for regulated healthcare and life sciences organizations across the cell and gene therapy ecosystem.
September 18, 2025
Title21 Health Solutions announces the outcomes of its inaugural Advisory Council meeting, where industry leaders identified interoperability and cross-sector collaboration as two of the most pressing challenges in the CGT industry.
May 6, 2025
Title21 is thrilled to announce the formation of our inaugural Advisory Committee, which will bring together five distinguished leaders in cell and gene therapy (CGT) to guide the evolution of our CGT platform!
April 8, 2025
Title21 announces the addition of Jonathan Wofford as the company’s first Chief Commercial Officer (CCO) to oversee the company’s products, sales, and marketing efforts.
December 10, 2024
We are pleased to announce that Tony Pare has assumed the role of CEO for Title21 Health Solutions.